NM_000037.4(ANK1):c.499G>C (p.Gly167Arg) AND Spherocytosis type 1

Clinical significance:Conflicting interpretations of pathogenicity, Benign(1);Uncertain significance(1) (Last evaluated: May 21, 2019)

Review status:1 star out of maximum of 4 stars

criteria provided, conflicting interpretations

Based on:
2 submissions [Details]
Record status:
current
Accession:
RCV001002597.2

Allele description [Variation Report for NM_000037.4(ANK1):c.499G>C (p.Gly167Arg)]

NM_000037.4(ANK1):c.499G>C (p.Gly167Arg)

Gene:
ANK1:ankyrin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8p11.21
Genomic location:
Preferred name:
NM_000037.4(ANK1):c.499G>C (p.Gly167Arg)
HGVS:
  • NC_000008.11:g.41725874C>G
  • NG_012820.1:g.175889G>C
  • NG_012820.2:g.175889G>C
  • NM_000037.4:c.499G>CMANE SELECT
  • NM_001142446.2:c.598G>C
  • NM_020475.3:c.499G>C
  • NM_020476.3:c.499G>C
  • NM_020477.3:c.499G>C
  • NP_000028.3:p.Gly167Arg
  • NP_001135918.1:p.Gly200Arg
  • NP_065208.2:p.Gly167Arg
  • NP_065209.2:p.Gly167Arg
  • NP_065210.2:p.Gly167Arg
  • NC_000008.10:g.41583392C>G
  • NM_000037.3:c.499G>C
Protein change:
G167R
Links:
dbSNP: rs201024919
NCBI 1000 Genomes Browser:
rs201024919
Molecular consequence:
  • NM_000037.4:c.499G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001142446.2:c.598G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020475.3:c.499G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020476.3:c.499G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020477.3:c.499G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Spherocytosis type 1 (SPH1)
Synonyms:
SPHEROCYTOSIS, HEREDITARY, 1; ANK1-Related Spherocytosis
Identifiers:
MONDO: MONDO:0008447; MedGen: C2674218; Orphanet: 822; OMIM: 182900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001160570ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratoriescriteria provided, single submitter
Uncertain significance
(May 21, 2019)
germlineclinical testing

Citation Link,

SCV001325498Illumina Clinical Services Laboratory,Illuminacriteria provided, single submitter
Benign
(Jan 15, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories, SCV001160570.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Illumina Clinical Services Laboratory,Illumina, SCV001325498.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 6, 2020

Support Center